Baseimmune

A data-driven platform specialised in pathogen analysis for antigen discovery and vaccine design

Add To Watchlist
General Information
Company Name
Baseimmune
Founded Year
2019
Location (Offices)
London, United Kingdom +1
Founders / Decision Makers
Joshua Blight - Co-Founder & CEO Ariane Gomes - Co-founder and CSO Phillip Kemlo - Founder & Chief Technical Officer
Number of Employees
22
Industries
Biotechnology, Health Care, Life Sciences
Funding Stage
Series A
Social Media

Baseimmune - Company Profile

Baseimmune is a UK-based startup that was founded in 2019 with a focus on antigen discovery and vaccine development. The company's slogan, "A data-driven platform specialised in pathogen analysis for antigen discovery and vaccine design", reflects its core mission. With a strong presence in the biotechnology and health care industries, Baseimmune recently secured a significant £9.00M Series A investment on 26 February 2024. This investment round saw participation from a notable group of investors including Hoxton Ventures, Beast Ventures, Creator Fund, IQ Capital, Maki.vc, and Merck Global Health Innovation Fund.

Taxonomy: pathogen analysis, antigen discovery, vaccine design, data-driven platform, startup, vaccine development, discovery phase, biomedical research

Funding Rounds & Investors of Baseimmune (3)

View All
Funding Stage Amount No. Investors Investors Date
Series A £9.00M 6
Hoxton Ventures, investor in Baseimmune's Series A round Beast Ventures, investor in Baseimmune's Series A round Creator Fund, investor in Baseimmune's Series A round IQ Capital, investor in Baseimmune's Series A round Maki.vc, investor in Baseimmune's Series A round
Merck Global Health Innovation Fund 		26 Feb 2024
Seed Round £3.50M 4
Cherry Ventures, investor in Baseimmune's Seed Round round Hoxton Ventures, investor in Baseimmune's Seed Round round Creator Fund, investor in Baseimmune's Seed Round round Maki.vc, investor in Baseimmune's Seed Round round
02 Nov 2021
Seed Round £685.00K - 01 Apr 2021

Latest News of Baseimmune

View All
Bristol-based Empirical Ventures targets €11.6 million fund to lead early-stage deep science rounds

Bristol-based Empirical Ventures targets €11.6 million fund to lead early-stage deep science rounds

Eu-startups Apr 04, 2024

Similar Companies to Baseimmune

View All
AiBIOLOGICS - Similar company to Baseimmune
AiBIOLOGICS Advancing antibody, diagnostics and vaccine discovery through the power of artificial intelligence
Prellis Biologics - Similar company to Baseimmune
Prellis Biologics Integrating human biology with machine learning for antibody discovery
Integral Molecular - Similar company to Baseimmune
Integral Molecular The Industry Leader In Membrane Protein Solutions
Syntekabio Inc. - Similar company to Baseimmune
Syntekabio Inc. AI Platform for Drug Discovery & Precision Medicine (226330:KOSDAQ)
Algonomics - Similar company to Baseimmune
Algonomics Innovative bioinformatics for rationally designed immunotherapeutics through advanced protein and peptide interaction platforms.
Circle Decoration Circle Decoration

Want to dive deeper into Baseimmune? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now